1. Predicting the rate of cognitive decline in aging and early Alzheimer disease;Adak;Neurology,2004
2. Evaluation of CSF-tau and CSF-Abeta42 as diagnostic markers for Alzheimer disease in clinical practice;Andreasen;Arch. Neurol.,2001
3. Apostolova, L.G., Beyer, M.K., Green, A.E., Hwang, K.S., Morra, J.H., Chou, Y.Y., Avedissian, C., Aarsland, D., Janvin, C.C., Larsen, J.P., Cummings, J.L., Thompson, P.M. (2008). Hippocampal, caudate and ventricular changes in Parkinson's disease with and without dementia, Neurology, under revision, Nov. 17, 2008.
4. Apostolova, L.G., Thompson, P.M., Green, A.H., Hwang, K., Zoumalan, C., Jack, C.R., Harvey, D., Petersen, R.M., Thal, L., Aisen, P., Toga, A.W., Cummings, J.L., DeCarli, C. for the ADCS Group (submitted for publication). 3D comparison of low, intermediate, and advanced hippocampal atrophy in MCI, submitted, Sept. 2008.
5. Apostolova, L.G., Beyer, M.K., Green, A.E., Hwang, K.S., Morra, J.H., Chou, Y.Y., Avedissian, C., Aarsland, D., Janvin, C.C., Larsen, J.P., Cummings, J.L., Thompson, P.M. (submitted for publication). Automated 3D mapping of hippocampal and caudate atrophy and ventricular enlargement in Parkinson's disease with and without dementia, to be submitted to Neurology, Sept. 2008.